Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.
暂无分享,去创建一个
W. Abhayaratna | J. McVernon | I. Barr | W. J. McBride | J. Carapetis | S. Rockman | H. Marshall | F. de Looze | R. Booy | S. Shakib | P. Richmond | W. Rawlinson | T. Nolan | M. Greenberg | J. Reid | L. Heron | R. Basser | Michael H. Lai | S. Carson | J. Karrasch | R. Ellis-Pegler | Russell L Basser | Gunter F Hartel | Gunter F. Hartel
[1] R. Shaban,et al. ‘The Australian Immunisation Handbook 8th Edition’. National Health and Medical Research Council, Australian Government. Canberra: Commonwealth of Australia; 2003. 350 pages, ISBN 0-642-82204-2 , 2015 .
[2] M. Ng,et al. Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere trivalent influenza vaccine is associated with adverse events. , 2014, Vaccine.
[3] S. Koernig,et al. Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine. , 2014, Vaccine.
[4] J. Wong,et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] Robert Booy,et al. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. , 2012, Vaccine.
[6] B. Cowling,et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] D. Bernstein,et al. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. , 2010, Vaccine.
[8] R. Webby,et al. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner. , 2010, The Journal of infectious diseases.
[9] H. Kelly,et al. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[10] Alberto Arnedo-Pena,et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. , 2010, Vaccine.
[11] P. Orellano,et al. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. , 2010, Vaccine.
[12] Christopher L. Perdue,et al. Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel , 2010, PloS one.
[13] K. Subbarao,et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. , 2010, The Journal of clinical investigation.
[14] A. Cook,et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. , 2010, JAMA.
[15] D. Earn,et al. Pandemic (H1N1) 2009 Risk for Nurses after Trivalent Vaccination , 2010, Emerging infectious diseases.
[16] Laura C. Rosella,et al. Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.
[17] J. McVernon,et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. , 2010, JAMA.
[18] Derek A T Cummings,et al. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. , 2009, The New England journal of medicine.
[19] Víctor Hugo Borja-Aburto,et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis , 2009, The Lancet.
[20] M. Greenberg,et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. , 2009, The New England journal of medicine.
[21] C. Reed,et al. Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Libo Dong,et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.
[23] L. Finelli,et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.
[24] J. McVernon,et al. Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children , 2009, Influenza and other respiratory viruses.
[25] Eduardo Lazcano-Ponce,et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City , 2009, BMJ : British Medical Journal.
[26] H. Kelly,et al. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[27] C. Macken,et al. Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] Nicholas S. Kelley,et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.
[29] L. Balluz,et al. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. , 2009, MMWR. Morbidity and mortality weekly report.
[30] T. Popović,et al. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. , 2009, MMWR. Morbidity and mortality weekly report.